Register for our free email digests:
Latest From AtheroNova Inc.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- AtheroNova Inc.
- Senior Management
Thomas W Gardner, CEO
Mark Selawski, CFO
Balbir Brar, PhD, SVP, Drug Dev.
- Contact Info
Phone: (949) 476-1100
2301 Dupont Dr.
Irvine, CA 92612
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.